Stockreport
Prezent Launches Prezent Vivo: The First Communication Partner for Life Sciences that Fuses AI and Experts into One [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PALO ALTO, Calif. April 28, 2026 /PRNewswire/ -- Prezent, the communications platform trusted by over 150 Life Sciences companies including 45 of the top 50 BioPharma, today launched Prezent Vivo — the first partner that fuses purpose-built AI and domain experts to power the entire Life Sciences communication ecosystem, serving both BioPharma companies and their agency partners. Introducing Prezent Vivo: Fusing AI + human expertise to power Life Sciences Communications With Vivo, Prezent goes beyond presentations to deliver Life Sciences communications across the full product lifecycle - congress posters, data visualization, scientific documents, brochures, MSL narrative decks, advisory board materials, national sales meetings and more. The company also appointed Francine Carrick , a 22-year MedComms veteran, as President of Prezent Vivo. Life Sciences teams have long faced a false choice between general-purpose AI that delivers speed without substance and traditional agencies
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences (GILD) had its price target raised by Morgan Stanley from $171.00 to $175.00. They now have an "overweight" rating on the stock.[MarketBeat]
- U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir[Business Wire]
- Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel[Business Wire]
- Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock [Yahoo! Finance][Yahoo! Finance]
- 2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 4
- 4/28/26 - Form 144
- GILD's page on the SEC website
- More